CLINICAL_TRIALS trial_result · 2023-08-30

Clinical Trial Update: Medical Treatment of "High-Risk" Neurofibromas [Phase 2]

Phase 2 clinical trial update on medical treatment of high-risk neurofibromas in Neurofibromatosis type 1 has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Corewell Health West | Conditions: Neurofibromatosis 1 | Phase 2 | Status: COMPLETED | Results posted: 2023-08-30